Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D01145 Azelnidipine (JP18/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
D01145 Azelnidipine
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
D01145 Azelnidipine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D01145 Azelnidipine
Drug classes [BR:br08332]
Cardiovascular agent
DG01928 Dihydropyridine calcium channel blocker
D01145 Azelnidipine
DG03231 Antihypertensive
D01145 Azelnidipine
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D01145 Azelnidipine (JP18/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01145 Azelnidipine
D01145 Azelnidipine tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01145
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01145
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01145